Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a significant decrease in short interest in June. As of June 15th, there was short interest totaling 142,536 shares, a decrease of 36.8% from the May 31st total of 225,427 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 897,604 shares, the short-interest ratio is currently 0.2 days.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CLPBY shares. The Goldman Sachs Group downgraded Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Coloplast A/S currently has an average rating of “Hold”.

Coloplast A/S Stock Up 5.0%

Coloplast A/S stock traded up $0.29 during trading hours on Thursday, hitting $6.06. The company had a trading volume of 64,311 shares, compared to its average volume of 561,154. Coloplast A/S has a fifty-two week low of $5.64 and a fifty-two week high of $10.03. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09. The firm has a market capitalization of $13.66 billion, a P/E ratio of 43.29, a price-to-earnings-growth ratio of 1.80 and a beta of 0.22. The firm’s fifty day moving average is $6.13 and its 200-day moving average is $7.19.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. On average, research analysts forecast that Coloplast A/S will post 0.4 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.